News: 2023
MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology
March 28, 2023
Strategic Partnership Mimetas - Astellas
Read more
Modra Pharmaceuticals Announces U.S. Patent Issuance for ModraDoc006/r
March 16, 2023
U.S. Patent and Trademark Office (USPTO) has issued to Modra U.S. Patent No. 11,571,408, covering the use of its oral taxane therapeutic ModraDoc006/r.
Read more
CliCr® and CliCr® derivatives are available via Iris Biotech GmbH
January 26, 2023
Iris Biotech sells CliCr® and CliCr® reagents.
Read more
Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
January 17, 2023
- Cristal Therapeutic CliCr® technology and McSAF Inside® technology will be integrated into the Lonza Bioconjugation Toolbox...
Read more
